secwatch.observer — SEC 8-K summary
======================================

Issuer:     LISATA THERAPEUTICS, INC. (LSTA)
CIK:        0000320017
Form:       8-K
Filed at:   2026-07-17T11:01:28+00:00
Accession:  0001140361-26-028763
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.30
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Lisata Therapeutics extends merger outside date with Kuva Labs to July 21, 2026
-------------------------------------------------------------------------------

- Amendment extends Outside Date from July 17 to July 21, 2026.
- Merger agreement originally dated March 6, 2026, with Kuva Labs Inc.
- Extension provides additional time to satisfy closing conditions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/320017/000114036126028763/0001140361-26-028763-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/320017/000114036126028763/ef20078184_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-26-028763

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer